Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrazoxane in STEMI
NCT07502521Phase 2Completed
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute myocardial infarction (AMI) comparing Dexrazoxane Infusion with Placebo Infusion (2 arms). Primary endpoints: Left Ventricular Ejection Fraction and Intramyocardial Haemorrhage Burden. Started Aug 2025; status: completed.
02
Drugs
dexrazoxane
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT07502521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07502521.